Notícias Eulerpool Radiopharm Theranostics

Radiopharm Theranostics Eulerpool-AFX

Radiopharm Theranostics Notícias de ações

Radiopharm Theranostics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Radiopharm Theranostics nós reunimos aqui.

• 20 de setembro ·

  Yahoo
  Radiopharm Theranostics Non-Executive Director Acquires 430% More Stock
• 21 de junho ·

  Yahoo
  Radiopharm Receives Strategic Investment for up to A$18 million
• 9 de outubro ·

  Yahoo
  RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody in Non-Small Cell Lung Cancer
• 1 de setembro ·

  Yahoo
  Radiopharm Theranostics Full Year 2023 Earnings: AU$0.11 loss per share (vs AU$0.17 loss in FY 2022)
• 24 de agosto ·

  Yahoo
  Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer
• 9 de junho ·

  Yahoo
  Diamond Equity Research to Host Global Select Emerging Growth Invitational Virtual Investor Conference on June 13th, 2023
• 9 de maio ·

  Yahoo
  Radiopharm Theranostics Receives FDA Orphan Drug Designation for Trivehexin (RAD 301) in Pancreatic Cancer
• 18 de abril ·

  Yahoo
  Radiopharm Theranostics secures pivotal isotope for cancer-targeting peptide
• 17 de abril ·

  Yahoo
  Radiopharm Theranostics Enters Into Supply Agreement with TerThera for Terbium-161 Isotope
• 28 de março ·

  Yahoo
  Radiopharm Theranostics Invited to Participate in Jefferies Radiopharma Innovation Summit